D-0086-2024 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0086-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 13, 2023 and is designated Class II. Reason for recall: Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg. The recall status is terminated (terminated Sep 9, 2024). Affected quantity: 1,656 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 15, 2023
Initiation Date
Oct 13, 2023
Termination Date
Sep 9, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,656 bottles

Product description

Montelukast Sodium Tablets, USP 10 mg, Rx Only, 1000 count bottle, Distributed by: Dr. Reddy's Laboratories., Princeton, NJ 08540, Made in India, NDC# 55111-725-10.

Reason for recall

Presence of Foreign Tablet(s)/Capsule(s): A foreign tablet was found in a bottle of Montelukast Sodium Tablets, USP 10mg, identified as metoprolol 25 mg.

Distribution pattern

Nationwide

Code information

Lot # C2305569, Exp. date 03/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0086-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0086-2024. Report a data issue: hello@regdatalab.com.